Plants have historically provided effective antimicrobial agents, such as emetine, quinine, and berberine, which have been used for centuries to combat microbial infections. Modern research continues to explore the potential of plant-derived antimicrobials, particularly in the context of drug-resistant infections and emerging diseases. Plants like Hydrastis canadensis (goldenseal), Garcinia kola, and Aframomum melegueta have shown significant antimicrobial, antifungal, and antiviral properties. These plants are also used in traditional African medicine for various ailments, including infections, fever, and digestive issues. Infectious diseases remain a major cause of death globally, especially in tropical regions. In developed countries, the rise in drug-resistant infections and the emergence of new pathogens have increased the need for new antimicrobial agents. The development of new antimicrobials is a priority, with a focus on natural products from plants. The third generation of phytotherapeutic agents involves clinical evaluation before identifying active constituents, ensuring safety and efficacy. Plants offer a promising alternative to synthetic antimicrobials due to their safety profile and potential for treating infections while minimizing side effects. They are also economically beneficial, with a growing market for herbal products. The demand for plant-based antimicrobials is increasing, driven by consumer interest in natural products and the need for sustainable solutions to public health challenges. Several plants, including Cryptolepis sanguinolenta, Chasmanthera dependens, and Nauclea latifolia, have shown antimicrobial activity against various bacteria and fungi. These plants are being studied for their potential in developing new antimicrobial drugs. The integration of traditional knowledge with modern scientific methods is crucial for the development of effective plant-based antimicrobials. Continued research and exploration of plant-derived compounds are essential to address the growing threat of infectious diseases and to harness the therapeutic potential of plants.Plants have historically provided effective antimicrobial agents, such as emetine, quinine, and berberine, which have been used for centuries to combat microbial infections. Modern research continues to explore the potential of plant-derived antimicrobials, particularly in the context of drug-resistant infections and emerging diseases. Plants like Hydrastis canadensis (goldenseal), Garcinia kola, and Aframomum melegueta have shown significant antimicrobial, antifungal, and antiviral properties. These plants are also used in traditional African medicine for various ailments, including infections, fever, and digestive issues. Infectious diseases remain a major cause of death globally, especially in tropical regions. In developed countries, the rise in drug-resistant infections and the emergence of new pathogens have increased the need for new antimicrobial agents. The development of new antimicrobials is a priority, with a focus on natural products from plants. The third generation of phytotherapeutic agents involves clinical evaluation before identifying active constituents, ensuring safety and efficacy. Plants offer a promising alternative to synthetic antimicrobials due to their safety profile and potential for treating infections while minimizing side effects. They are also economically beneficial, with a growing market for herbal products. The demand for plant-based antimicrobials is increasing, driven by consumer interest in natural products and the need for sustainable solutions to public health challenges. Several plants, including Cryptolepis sanguinolenta, Chasmanthera dependens, and Nauclea latifolia, have shown antimicrobial activity against various bacteria and fungi. These plants are being studied for their potential in developing new antimicrobial drugs. The integration of traditional knowledge with modern scientific methods is crucial for the development of effective plant-based antimicrobials. Continued research and exploration of plant-derived compounds are essential to address the growing threat of infectious diseases and to harness the therapeutic potential of plants.